Unraveling Acute and Post-COVID Cytokine Patterns to Anticipate Future Challenges

Keyphrases

• Disease Severity 100%
• COVID-19 100%
• Cytokine Pattern 100%
• Post-COVID 100%
• Interleukin-8 66%
• Cytokine Profile 66%
• Interleukin-15 (IL-15) 66%
• Coronavirus Infections 66%
• Fibroblast Growth Factor 2 (FGF2) 66%
• Immune Response 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Therapeutic Target 33%
• Severe Disease 33%
• COVID-19 Complications 33%
• COVID-19 Patients 33%
• Vascular Endothelial Growth Factor 33%
• Interleukin-10 33%
• Arterial Hypertension 33%
• Interleukin-6 33%
• Multiplex Analysis 33%
• Disease Progression 33%
• Acute Phase 33%
• Acute Infection 33%
• Interleukin-12 (IL-12) 33%
• Targeted Intervention 33%
• Monocyte Chemoattractant protein-1 (MCP-1) 33%
• Potential Biomarkers 33%
• Interleukin-7 (IL-7) 33%
• Clinical High Risk 33%
• Interleukin-13 (IL-13) 33%
• Atherosclerosis Progression 33%
• IP-10 33%
• Infection Severity 33%
• Eotaxin 33%
• Fractalkine 33%
• Moderate Disease 33%
• Rapid Progression 33%
• Glucose Intolerance 33%
• Thyrotoxicosis 33%
• Elevated Levels 33%
• CD40L 33%
• Predicting Disease 33%
• Previously Diagnosed 33%

Immunology and Microbiology

• COVID-19 100%
• Cytokine 100%
• Infection 57%
• Infectious Disease 42%
• Coronavirinae 28%
• Fibroblast Growth Factor 2 28%
• Interleukin 15 28%
• Interleukin 8 28%
• Immune Response 14%
• Interleukin 6 14%
• Interleukin 10 14%
• Interleukin 13 14%
• Fractalkine 14%
• Eotaxin 14%
• Interleukin 7 14%
• Atherosclerosis 14%
• Vasculotropin A 14%
• Glucose 14%
• Therapeutic Target 14%

INIS

• cytokines 100%
• diseases 71%
• patients 57%
• covid-19 42%
• coronaviruses 28%
• comparative evaluations 14%
• levels 14%
• risks 14%
• interventions 14%
• biological markers 14%
• gain 14%
• diabetes mellitus 14%
• hypertension 14%
• glucose 14%
• atherosclerosis 14%
• thyrotoxicosis 14%